Navigation Links
Obese women likey for Cesarean

Fat women are more likely for Cesarean delivery, says Dr.Bell from Duke University NC.

Years ago, anesthesia had been one of the major causes of maternal mortality.// Pregnancy and obesity both make it difficult to breathe under general anesthesia, so a woman's risk is doubled when the two conditions are combined.

Bell and colleagues studied more than 3000 women and calculated each woman's body mass index (BMI), a measurement of body fat calculated using a formula that is based on height and weight, and related it to her chances of having a Cesarean section.

Women requiring the surgery were an average weight of 191 pounds and had an average BMI of 53, while women who delivered vaginally weighed an average of 182 pounds and had an average BMI of 31.

The researchers also found that the number of women who needed a C-section increased as BMI of a person increased. Among women with a BMI of 20 or less ( which indicates a low amount of body fat),had a normal delivery. Whereas if BMI ranged from 21-30 ( which indicates a range of body fat from healthy to a fatter proportion), the incidence was 0.3%, and when BMI was 31-40 (obesity), the incidence was 33% .

Women should take care against excessive weight gain while pregnant, to avoid unnecessary hassels.They should work to be in good shape for a normal delivery.


'"/>




Page: 1

Related medicine news :

1. Death Risk Higher in Obese Women with Colon Cancer
2. Prostate Cancer in Obese Men
3. Obese Kids Also Prone To Heart Attacks
4. Being Obese Increases Ones Risk Of A wrong Diagnosis During Medical Imaging
5. Being Obese Could Lead To Kidney Stone Formation
6. Obese people can be hypertensive as well
7. Obese children may have abnormalities of lipoproteins
8. Obese women with breast cancer may be under treated.
9. Obese Adults Undergo Less Medical Tests And More Vulnerable To Diseases
10. Obese Employees Increase Costs For Employers
11. Plump Infants Getting Obese Later In Life In More Cases
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/21/2017)... ... ... broad access to life-saving drugs and rewarding the innovators who develop those drugs often ... , That was the message from Dana Goldman, PhD, Leonard D. Schaeffer Chair and ... who served as the keynote speaker for Western University of Health Sciences’ Ray Symposium ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... Christopher Salas-Wright finds that youth violence is declining—and at noteworthy rates. Between 2002 ... proportion of young people involved in violence in the United States. The study, ...
(Date:4/21/2017)... ... April 21, 2017 , ... Evoke Therapy Programs , ... kicked off its 4th annual Forum for Innovative Treatment Solutions (FITS), which runs ... Therapy for Mental Health and Addiction.” , FITS’ 2017 keynote presenters will ...
(Date:4/21/2017)... ... April 21, 2017 , ... Young Asset Protection, ... to communities throughout the greater Pittsburgh metropolitan region, is joining forces with the ... bicycles for differently-abled children. , Variety the Children’s Charity is a national organization ...
(Date:4/21/2017)... ... April 21, 2017 , ... The adage “Show, don’t tell” applies ... project in the company’s esteemed VISION House demonstration project series. Manifesting the concept of ... of resources they need to live affordably and abundantly without unduly taxing the resources ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017   ZappRx, Inc ., a digital ... prescribing process, today announced it closed $25 million in Series ... capital firm based in Seattle that ... Partners . The Series B round included participation from ... 2014, and GV (formerly Google Ventures). As part ...
(Date:4/20/2017)... April 20, 2017 Research and Markets ... Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key ... to their offering. ... global pharmacogenomics market was valued at US$ 7,167.6 Mn in ... 2024, expanding at a CAGR of 5.6% from 2016 to ...
(Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
Breaking Medicine Technology: